RE:RE:Questions (don't bash pls) Thank you all for your thoughtful responses - it is a nice change compared to the typical bullboard craziness.
One thing I have persistently read amongst people here is that the stock has bottomed out or is showing resistance at 0.65. Why do you all say that?
It's reasonable to believe that this stock gets pushed into the 50's/40's/30's similar to THC and SUN. Obviously noone wants that but I don't see why that isn't a possibility here. I'm hoping their next NR is something truly significant - something associated with a phase 3 clinical trial.
I have cash on reserve to lower my buy price in the event it plummets but am hoping it doesn't come to that. Everyone is obviously hoping this turns into an AXIM Biotechnologies. By the way, what did push AXIM to that insane 52 week high they had?
One last thing, doesn't the recreational market hurt companies like TBP who are dabbling primarily in the medical market whereas their "product" or services are less useful since a user no longer really requires the whole "medicinal" system which for cannabis is a nightmare to deal with. Are they doing anything in the states or serve any sort of potential upside due to the looking medical market in the states?